# Esquire Financial Holdings, Inc.: financial statements, quarterly

ESQ · Nasdaq · CIK 1531031 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/esq.md) · [Financials](/companies/esq/financials.md) · [Filings](/companies/esq/filings.md) · [Insiders](/companies/esq/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/esq/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [2.2](/filings/0001558370-23-018602.md) | [2.9 d](/filings/0001558370-24-004363.md) | [3.2](/filings/0001558370-24-007806.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [3.5](/filings/0001558370-24-015539.md) | [3.7 d](/filings/0001104659-26-027706.md) | [3.6](/filings/0001558370-25-007325.md) | [3.9](/filings/0001558370-25-010928.md) | [4.2](/filings/0001104659-25-108508.md) | [3.9 d](/filings/0001104659-26-027706.md) | [4.1](/filings/0001104659-26-058451.md) | [3.4](/filings/0001104659-26-093295.md) | [3.4](/filings/0001104659-25-108508.md) | [4.0 d](/filings/0001104659-26-027706.md) | [4.9](/filings/0001104659-26-058451.md) | [5.1](/filings/0001104659-26-093295.md) |
| Net income | $m | [9.8](/filings/0001558370-24-015539.md) | [9.9 d](/filings/0001104659-26-027706.md) | [10.1](/filings/0001558370-25-007325.md) | [10.5](/filings/0001558370-25-010928.md) | [11.4](/filings/0001104659-25-108508.md) | [11.8 d](/filings/0001104659-26-027706.md) | [11.4](/filings/0001104659-26-058451.md) | [11.9](/filings/0001104659-26-093295.md) | [14.1](/filings/0001104659-25-108508.md) | [13.5 d](/filings/0001104659-26-027706.md) | [12.2](/filings/0001104659-26-058451.md) | [13.0](/filings/0001104659-26-093295.md) |
| Diluted EPS | $ per share | [1.17](/filings/0001558370-24-015539.md) | not reported | [1.20](/filings/0001558370-25-007325.md) | [1.25](/filings/0001558370-25-010928.md) | [1.34](/filings/0001104659-25-108508.md) | not reported | [1.33](/filings/0001104659-26-058451.md) | [1.38](/filings/0001104659-26-093295.md) | [1.62](/filings/0001104659-25-108508.md) | not reported | [1.40](/filings/0001104659-26-058451.md) | [1.49](/filings/0001104659-26-093295.md) |
| Basic EPS | $ per share | [1.27](/filings/0001558370-24-015539.md) | not reported | [1.29](/filings/0001558370-25-007325.md) | [1.34](/filings/0001558370-25-010928.md) | [1.45](/filings/0001104659-25-108508.md) | not reported | [1.43](/filings/0001104659-26-058451.md) | [1.48](/filings/0001104659-26-093295.md) | [1.74](/filings/0001104659-25-108508.md) | not reported | [1.48](/filings/0001104659-26-058451.md) | [1.57](/filings/0001104659-26-093295.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [121](/filings/0001558370-23-018602.md) | [165](/filings/0001558370-25-003114.md) | [158](/filings/0001558370-24-007806.md) | [153](/filings/0001558370-24-012203.md) | [148](/filings/0001558370-24-015539.md) | [126](/filings/0001104659-26-027706.md) | [173](/filings/0001558370-25-007325.md) | [163](/filings/0001558370-25-010928.md) | [241](/filings/0001104659-25-108508.md) | [236](/filings/0001104659-26-093295.md) | [222](/filings/0001104659-26-058451.md) | [242](/filings/0001104659-26-093295.md) |
| Total assets | $m | [1,482](/filings/0001558370-23-018602.md) | [1,617](/filings/0001558370-25-003114.md) | [1,654](/filings/0001558370-24-007806.md) | [1,716](/filings/0001558370-24-012203.md) | [1,782](/filings/0001558370-24-015539.md) | [1,893](/filings/0001104659-26-027706.md) | [1,954](/filings/0001558370-25-007325.md) | [2,060](/filings/0001558370-25-010928.md) | [2,184](/filings/0001104659-25-108508.md) | [2,366](/filings/0001104659-26-093295.md) | [2,421](/filings/0001104659-26-058451.md) | [2,511](/filings/0001104659-26-093295.md) |
| Total liabilities | $m | [1,297](/filings/0001558370-23-018602.md) | [1,418](/filings/0001558370-25-003114.md) | [1,447](/filings/0001558370-24-007806.md) | [1,498](/filings/0001558370-24-012203.md) | [1,550](/filings/0001558370-24-015539.md) | [1,655](/filings/0001104659-26-027706.md) | [1,704](/filings/0001558370-25-007325.md) | [1,796](/filings/0001558370-25-010928.md) | [1,905](/filings/0001104659-25-108508.md) | [2,076](/filings/0001104659-26-093295.md) | [2,120](/filings/0001104659-26-058451.md) | [2,197](/filings/0001104659-26-093295.md) |
| Shareholders' equity | $m | [186](/filings/0001558370-24-015539.md) | [199](/filings/0001104659-26-027706.md) | [207](/filings/0001558370-25-010928.md) | [217](/filings/0001104659-25-108508.md) | [233](/filings/0001104659-25-108508.md) | [237](/filings/0001104659-26-093295.md) | [251](/filings/0001104659-26-093295.md) | [264](/filings/0001104659-26-093295.md) | [279](/filings/0001104659-25-108508.md) | [290](/filings/0001104659-26-093295.md) | [301](/filings/0001104659-26-093295.md) | [314](/filings/0001104659-26-093295.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [10.8 d](/filings/0001558370-24-015539.md) | [16.5 d](/filings/0001104659-26-027706.md) | [12.8](/filings/0001558370-25-007325.md) | [7.2 d](/filings/0001558370-25-010928.md) | [10.5 d](/filings/0001104659-25-108508.md) | [11.7 d](/filings/0001104659-26-027706.md) | [15.8](/filings/0001104659-26-058451.md) | [10.5 d](/filings/0001104659-26-093295.md) | [16.8 d](/filings/0001104659-25-108508.md) | [16.8 d](/filings/0001104659-26-027706.md) | [19.5](/filings/0001104659-26-058451.md) | [14.5 d](/filings/0001104659-26-093295.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001558370-24-015539.md) | [0.3 d](/filings/0001104659-26-027706.md) | [0.2](/filings/0001558370-25-007325.md) | [0.3 d](/filings/0001558370-25-010928.md) | [0.1 d](/filings/0001104659-25-108508.md) | [0.1 d](/filings/0001104659-26-027706.md) | [1.2](/filings/0001104659-26-058451.md) | [1.2 d](/filings/0001104659-26-093295.md) | [0.5 d](/filings/0001104659-25-108508.md) | [0.3 d](/filings/0001104659-26-027706.md) | [0.2](/filings/0001104659-26-058451.md) | [0.2 d](/filings/0001104659-26-093295.md) |
| Dividends paid | $m | [0.8 d](/filings/0001558370-24-015539.md) | [1.1 d](/filings/0001104659-26-027706.md) | [1.2](/filings/0001558370-25-007325.md) | [1.2 d](/filings/0001558370-25-010928.md) | [1.2 d](/filings/0001104659-25-108508.md) | [1.3 d](/filings/0001104659-26-027706.md) | [1.4](/filings/0001104659-26-058451.md) | [1.4 d](/filings/0001104659-26-093295.md) | [1.4 d](/filings/0001104659-25-108508.md) | [1.6 d](/filings/0001104659-26-027706.md) | [1.7](/filings/0001104659-26-058451.md) | [1.7 d](/filings/0001104659-26-093295.md) |
| Share repurchases | $m | [0.0 d](/filings/0001558370-24-015539.md) | [0.0 d](/filings/0001104659-26-027706.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q1 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [8,226](/filings/0001558370-23-018602.md) | [8,303](/filings/0001558370-24-007806.md) | [8,300](/filings/0001558370-24-012203.md) | [8,379](/filings/0001558370-24-015539.md) | [8,402](/filings/0001558370-25-007325.md) | [8,403](/filings/0001558370-25-010928.md) | [8,504](/filings/0001104659-25-108508.md) | [8,602](/filings/0001104659-26-058451.md) | [8,639](/filings/0001104659-26-093295.md) | [8,690](/filings/0001104659-25-108508.md) | [8,700](/filings/0001104659-26-058451.md) | [8,726](/filings/0001104659-26-093295.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,104,583 at 2026-08-01, from the cover of the [10-Q filed 2026-08-10](/filings/0001104659-26-093295.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.